chart

Biotechs Rising as Buyouts Sweep the Market

It was only the second trading session of the year that Bristol Myers Squibb (BMY) gobbled up Celgene (CELG) in a record $74 billion deal. Loxo Oncology (LOXO) accepted an $8 billion bid from Eli Lilly (LLY) a few days later.

Is This Nasdaq Stock Revving Higher?

Tesla Motors (TSLA) has traded in a tight range since late October, even as volatility swept the broader market. Some potentially important things have happened during that time, including a so-called “golden cross” chart pattern.